COVID-19相关ARDS患者中的曲霉性气管支气管炎:队列研究
本研究为单中心回顾性队列研究,针对COVID-19相关ARDS患者中CAPA合并曲霉性气管支气管炎(ATB)的情况进行分析。摘要指出ATB在CAPA患者中患病率较高,本研究总体死亡率为75%,并强调对疑似侵袭性真菌感染的COVID-19 ARDS患者需进行全面检查。
要点
- ATB是CAPA的亚实体,支气管镜下可表现为溃疡、假膜、斑块和焦痂。
- 本研究中CAPA合并ATB患者总体死亡率为75%。
- 疑似侵袭性真菌感染的COVID-19 ARDS患者需全面检查以诊断ATB。
核心结论
- 曲霉性气管支气管炎在CAPA患者中患病率较高,本研究总体死亡率为75%。
研究设计与样本
- 单中心回顾性队列研究。
主要发现
- CAPA患者中ATB患病率较高。
- 本研究ATB患者总体死亡率为75%。
关键数值与推荐
- 2020年ECMM/ISHAM共识标准将ATB列为CAPA的亚实体。
- 支气管镜下ATB表现为溃疡、假膜、斑块和焦痂,可能合并气管狭窄。
临床怎么用
- 对COVID-19 ARDS患者,尤其疑似侵袭性真菌感染时应进行全面检查。
- 支气管镜检查可识别ATB,但需注意SARS-CoV-2传播风险。
- 盲法上气道吸引(气管吸出物和非支气管镜灌洗)无法观察气道,不能确诊ATB。
局限性
- 为单中心回顾性研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Comprehensive work-up is needed for COVID-19 ARDS patients, especially when suspecting invasive fungal infections. Aspergillus tracheobronchitis has a substantial prevalence in patients with CAPA accounting for an overall mortality of 75% in this study. https://bit.ly/3uF3FZU Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic, patients with acute respiratory distress syndrome (ARDS) due to SARS-CoV-2 showed a profoundly altered immune system and received immune-modulating therapeutic interventions. This enhanced the susceptibility for fungal superinfections [1, 2]. With the first reports of COVID-19-associated pulmonary aspergillosis (CAPA) the 2020 European Confederation of Medical Mycology (ECMM)/International Society for Human and Animal Mycology (ISHAM) consensus criteria were proposed [3, 4] and Aspergillus tracheobronchitis (ATB) was distinguished as a sub-entity in CAPA [4–6]. During bronchoscopy, ATB presents as ulcerations, pseudomembranes, plaques and eschars, possibly combined with tracheal stenosis [5]. Facing the risk of transmission and SARS-CoV-2 infection of examiners during bronchoscopy, blind suctioning of upper airway samples has been implemented with tracheal aspirates (TA) and non-bronchoscopic lavages. These techniques preclude inspection of the airways, so that ATB cannot be diagnosed beyond the level of suspicion. To study ATB in CAPA patients, we performed a retrospective, single-centre cohort study.
引用
- Koehler P, von Stillfried S, Garcia Borrega J, et al. Aspergillus tracheobronchitis in COVID-19 patients with acute respiratory distress syndrome: a cohort study. Eur Respir J. 2022. PMID: 35144992. doi:10.1183/13993003.03142-2021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。